Lal PathLabs informs about press release

26 Nov 2025 Evaluate
Pursuant to Regulation 30 of the Listing Regulations, Lal PathLabs has informed that it enclosed the Press Release titled ‘Dr. Lal PathLabs Strengthens Autoimmune Diagnosis with India’s First Comprehensive Complement Lab’.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

1359.05 -47.65 (-3.39%)
04-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7666.40
Max Healthcare Inst 1053.70
Narayana Hrudayalay 1740.25
Aster DM Healthcare 649.55
Global Health 1110.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×